Optimizing the Potential Utility of Blue-Blocking Glasses for Sleep and Circadian Health

Purpose: Wearable filters that reduce light in the short wavelength region of the visible spectrum, or “blue-blocking glasses,” are increasingly available and offer an individualized, low-cost tool for enhancing sleep and circadian health. However, their effectiveness depends on filtering properties, application, timing, and implementation. If these factors are disregarded, blue-blocking glasses may be ineffective or lead to counterproductive outcomes. Methods: We introduce a new metric, melanopic daylight filtering density (mDFD), to quantify a filter’s capacity to decrease melanopic input, providing an alternative to adhoc measures. We applied mDFD to 26 commercially available glasses, estimating their potential to reduce circadian and related physiological effects of light across common applications in the context of consensus-based metrics and recommendations. We also reviewed intervention studies that used blue-blocking glasses. Results: Products varied considerably in mDFD, with only those rated at mDFD ≥1 providing sufficient reductions in melanopic input to justify the “blue-blocking” label and associated claims. At least one relevant sleep or circadian-related outcome improved with blue-blocking interventions in the studies reviewed. In addition to filtering strength, appropriate timing and usage are critical to effectiveness. Conclusions: The efficacy of blue-blocking glasses depends on both spectral filtering and proper usage. The mDFD metric offers a consistent, evidence-based approach for evaluating, selecting, and designing products that reduce photic input for non-visual physiological effects of light. Translational Relevance: Standardized characterization of blue-blocking glasses using mDFD facilitates reliable product comparisons, evidence-based selection, and rational design of lenses that are optimized for circadian health across a range of applications.